Trial Site Detail

 

Drug:
Imatinib + AT13387
Trial:
A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Johns Hopkins Sidney Kimmel Comp Cancer Center

     
Baltimore , MD 21231
USA

 

Principal Investigator:
 Christian Meyer
Contact:
 Margaret Fogle Ferreira, RN 410-955-7349 mfogle1@jhmi.edu
Activation Status of this Site:
 Closed
Notes about this Site:
Johns Hopkins Sidney Kimmel Comp Cancer Center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.